Program Integrity Portal FWA Reporting Module - Part D Plans (CMS-10517)
Reinstatement with change of a previously approved collection
No
Regular
Comment filed on proposed rule
01/19/2021
02/21/2020
The requirement that "Make information concerning enrollee eligibility criteria available to CMS" is an authority to collect information, not a collection of information within the meaning of the Paperwork Reduction Act. Should CMS wish to collect information from 10 or more covered persons using this authority, CMS shall submit a separate PRA package.
Along with the submission of the final rule PRA package, the agency should provide to OMB a summary of all comments received on the proposed information collection and identify any changes made in response to these comments.
Inventory as of this Action
Requested
Previously Approved
36 Months From Approved
0
0
0
0
0
0
0
0
0
Formerly known as the Predictive Learning Analytics Tracking Outcome (PLATOTM) which is no longer operational.
Section 6063 of the SUPPORT ACT requires HHS to establish a secure web-based program integrity portal (or other successor technology) that would allow secure communication among the Secretary, MA and Part D plan sponsors, as well as eligible entities with a contract under section 1893, such as Medicare program integrity contractors. The program integrity portal would serve as the core repository for the data addressed in sections 2008 and 6063 of the SUPPORT Act. These provisions of the SUPPORT Act require Part D plan sponsors to have procedures to identify, and must report to CMS or its designee either of the following: any payment suspension implemented by a plan, pending investigation of credible allegations of fraud by a pharmacy, which must be implemented in the same manner as the Secretary does under section 1862(o)(1) of the Act; and any information related to the inappropriate prescribing of opioids and concerning investigations, credible evidence of suspicious activities of a provider of services (including a prescriber) or supplier, and other actions taken by the plan. The required data shall be submitted via the program integrity portal. In addition, the plans may report a referral, through the portal, of substantiated or suspicious activities of a provider of services (including a prescriber) or a supplier related to fraud, waste and abuse to initiate or assist with investigations conducted by CMS, or its designee, a Medicare program integrity contractor, or law enforcement partners.
This 2020 collection of information request proposes to reinstate – with change – our 0938-1262 control number that was associated with PLATO™ (Predictive Learning Analytics Tracking Outcome) which is no longer operational. The reinstatement is associated with our February 18, 2020 (85 FR 9002) proposed regulatory changes (CMS-4190-P, RIN 0938-AT97) which reflect the planned program integrity portal and the new data required in the proposed regulation.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
02/21/2020
Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.
CMS-10517 - Supporting Statement A (2020 CMS-4190-P version 5).docx
Subsequent Years